Division of Hematology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Acta Biochim Biophys Sin (Shanghai). 2009 Dec;41(12):973-9. doi: 10.1093/abbs/gmp091.
Chemerin is a novel chemoattractant recognized by chemokine-like receptor 1 (CMKLR1), a serpentine receptor expressed primarily by plasmacytoid dendritic cells, natural killer cells, and macrophages. Human prochemerin circulates in plasma as an inactive precursor. Its chemotactic activity is expressed upon cleavage of the C-terminal amino acid residues by proteases of the coagulation, fibrinolytic, and inflammatory system. The C-terminal cleavage site of prochemerin is highly conservative, indicating that the proteolytic regulation of chemerin bioactivity is a common mechanism undertaken by different species. In this review, we summarized chemerin-proteases interactions, chemerin receptors, and their importance in normal and pathologic conditions.
Chemerin 是一种新型趋化因子,可被趋化因子样受体 1(CMKLR1)识别,CMKLR1 是一种主要表达于浆细胞样树突状细胞、自然杀伤细胞和巨噬细胞的蛇型受体。人亲chemerin 以无活性前体的形式循环于血浆中。其趋化活性在凝血、纤溶和炎症系统的蛋白酶切割 C 末端氨基酸残基后表达。亲 chemerin 的 C 末端切割位点高度保守,表明 chemerin 生物活性的蛋白水解调节是不同物种共有的机制。在这篇综述中,我们总结了 chemerin-蛋白酶相互作用、chemerin 受体及其在正常和病理条件下的重要性。